Advanced Medical Solutions Group plc (AMS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Advanced Medical Solutions Group plc (AMS) has a cash flow conversion efficiency ratio of 0.061x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX15.97 Million ≈ $1.94K USD) by net assets (GBX260.10 Million ≈ $31.65K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Advanced Medical Solutions Group plc (AMS) market capitalisation for the company's overall valuation and market capitalisation.
Advanced Medical Solutions Group plc - Cash Flow Conversion Efficiency Trend (1994–2025)
This chart illustrates how Advanced Medical Solutions Group plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Advanced Medical Solutions Group plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Advanced Medical Solutions Group plc ranked by their cash flow conversion efficiency. Explore AMS cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Magmatic Resources Ltd
AU:MAG
|
-0.148x |
|
Energy Development Company Limited
NSE:ENERGYDEV
|
-5.422x |
|
Streamplay Studio Ltd
AU:SP8
|
-0.037x |
|
Superior Resources Ltd
AU:SPQ
|
-0.025x |
|
Deutsche Grundstücksauktionen AG
XETRA:DGR
|
0.022x |
|
XOX Bhd
KLSE:0165
|
0.194x |
|
Nyrstar NV
BR:NYR
|
0.000x |
|
Petro-Victory Energy Corp
V:VRY
|
0.095x |
Annual Cash Flow Conversion Efficiency for Advanced Medical Solutions Group plc (1994–2025)
The table below shows the annual cash flow conversion efficiency of Advanced Medical Solutions Group plc from 1994 to 2025. View current stock price of Advanced Medical Solutions Group plc for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | GBX260.10 Million ≈ $31.65K |
GBX28.75 Million ≈ $3.50K |
0.111x | +36.97% |
| 2024-12-31 | GBX241.52 Million ≈ $29.39K |
GBX19.49 Million ≈ $2.37K |
0.081x | +59.63% |
| 2023-12-31 | GBX244.20 Million ≈ $29.71K |
GBX12.35 Million ≈ $1.50K |
0.051x | -55.49% |
| 2022-12-31 | GBX236.62 Million ≈ $28.79K |
GBX26.88 Million ≈ $3.27K |
0.114x | -22.14% |
| 2021-12-31 | GBX212.68 Million ≈ $25.88K |
GBX31.02 Million ≈ $3.77K |
0.146x | +37.13% |
| 2020-12-31 | GBX202.21 Million ≈ $24.60K |
GBX21.51 Million ≈ $2.62K |
0.106x | -6.25% |
| 2019-12-31 | GBX191.24 Million ≈ $23.27K |
GBX21.70 Million ≈ $2.64K |
0.113x | -9.58% |
| 2018-12-31 | GBX172.72 Million ≈ $21.02K |
GBX21.67 Million ≈ $2.64K |
0.125x | +12.74% |
| 2017-12-31 | GBX152.44 Million ≈ $18.55K |
GBX16.97 Million ≈ $2.06K |
0.111x | -29.53% |
| 2016-12-31 | GBX125.53 Million ≈ $15.27K |
GBX19.82 Million ≈ $2.41K |
0.158x | -23.11% |
| 2015-12-31 | GBX103.66 Million ≈ $12.61K |
GBX21.29 Million ≈ $2.59K |
0.205x | +15.33% |
| 2014-12-31 | GBX93.05 Million ≈ $11.32K |
GBX16.57 Million ≈ $2.02K |
0.178x | +8.97% |
| 2013-12-31 | GBX86.09 Million ≈ $10.47K |
GBX14.07 Million ≈ $1.71K |
0.163x | +1.28% |
| 2012-12-31 | GBX73.70 Million ≈ $8.97K |
GBX11.89 Million ≈ $1.45K |
0.161x | +120.35% |
| 2011-12-31 | GBX66.21 Million ≈ $8.06K |
GBX4.85 Million ≈ $589.98 |
0.073x | -70.96% |
| 2010-12-31 | GBX27.80 Million ≈ $3.38K |
GBX7.01 Million ≈ $852.91 |
0.252x | +184.39% |
| 2009-12-31 | GBX22.85 Million ≈ $2.78K |
GBX2.03 Million ≈ $246.51 |
0.089x | -35.63% |
| 2008-12-31 | GBX19.89 Million ≈ $2.42K |
GBX2.74 Million ≈ $333.38 |
0.138x | -40.92% |
| 2007-12-31 | GBX15.75 Million ≈ $1.92K |
GBX3.67 Million ≈ $446.65 |
0.233x | +105.69% |
| 2006-12-31 | GBX13.05 Million ≈ $1.59K |
GBX1.48 Million ≈ $179.95 |
0.113x | +94.32% |
| 2005-12-31 | GBX11.85 Million ≈ $1.44K |
GBX691.00K ≈ $84.07 |
0.058x | +382.46% |
| 2004-12-31 | GBX11.57 Million ≈ $1.41K |
GBX-239.00K ≈ $-29.08 |
-0.021x | +82.69% |
| 2003-12-31 | GBX12.00 Million ≈ $1.46K |
GBX-1.43 Million ≈ $-174.23 |
-0.119x | -111.15% |
| 2002-12-31 | GBX14.11 Million ≈ $1.72K |
GBX-797.00K ≈ $-96.97 |
-0.056x | -69.83% |
| 2001-12-31 | GBX11.99 Million ≈ $1.46K |
GBX-399.00K ≈ $-48.55 |
-0.033x | +65.30% |
| 2000-12-31 | GBX13.45 Million ≈ $1.64K |
GBX-1.29 Million ≈ $-156.96 |
-0.096x | +73.78% |
| 1999-12-31 | GBX9.59 Million ≈ $1.17K |
GBX-3.51 Million ≈ $-426.70 |
-0.366x | -10.70% |
| 1998-12-31 | GBX14.73 Million ≈ $1.79K |
GBX-4.87 Million ≈ $-592.17 |
-0.330x | +48.54% |
| 1997-12-31 | GBX9.10 Million ≈ $1.11K |
GBX-5.84 Million ≈ $-710.32 |
-0.642x | +28.67% |
| 1996-12-31 | GBX5.06 Million ≈ $616.02 |
GBX-4.56 Million ≈ $-554.33 |
-0.900x | +22.21% |
| 1995-12-31 | GBX2.34 Million ≈ $284.71 |
GBX-2.71 Million ≈ $-329.36 |
-1.157x | -359.82% |
| 1994-12-31 | GBX5.04 Million ≈ $613.71 |
GBX-1.27 Million ≈ $-154.40 |
-0.252x | -- |
About Advanced Medical Solutions Group plc
Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, France, Europe, the United States, and internationally. It offers surgical products, such as tissue adhesives, sutures and clips, haemostats, biosurgical, internal fixation devices, infection c… Read more